Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1998 1
2001 1
2003 1
2004 2
2005 2
2006 1
2007 2
2008 2
2009 2
2010 3
2011 4
2012 1
2013 2
2014 3
2015 5
2016 2
2017 2
2018 3
2019 6
2020 10
2021 10
2022 9
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
The IASP classification of chronic pain for ICD-11: chronic neuropathic pain.
Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, Benoliel R, Cohen M, Cruccu G, Davis KD, Evers S, First M, Giamberardino MA, Hansson P, Kaasa S, Korwisi B, Kosek E, Lavand'homme P, Nicholas M, Nurmikko T, Perrot S, Raja SN, Rice ASC, Rowbotham MC, Schug S, Simpson DM, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ, Barke A, Rief W, Treede RD; Classification Committee of the Neuropathic Pain Special Interest Group (NeuPSIG). Scholz J, et al. Pain. 2019 Jan;160(1):53-59. doi: 10.1097/j.pain.0000000000001365. Pain. 2019. PMID: 30586071 Free PMC article. Review.
Diseases not explicitly mentioned in the classification are captured in residual categories of ICD-11. Conditions of chronic neuropathic pain are either insufficiently defined or missing in the current version of the ICD, despite their prevalence and clinical importance. . …
Diseases not explicitly mentioned in the classification are captured in residual categories of ICD-11. Conditions of chronic neuropat …
Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons.
Ratti A, Gumina V, Lenzi P, Bossolasco P, Fulceri F, Volpe C, Bardelli D, Pregnolato F, Maraschi A, Fornai F, Silani V, Colombrita C. Ratti A, et al. Neurobiol Dis. 2020 Nov;145:105051. doi: 10.1016/j.nbd.2020.105051. Epub 2020 Aug 20. Neurobiol Dis. 2020. PMID: 32827688 Free article.
We found that not only the acute sub-lethal stress usually used in literature, but also the chronic oxidative insult was able to induce SG formation in both primary fibroblasts and iPSC-MN. We also observed the recruitment of TDP-43 into SG only upon chronic stress …
We found that not only the acute sub-lethal stress usually used in literature, but also the chronic oxidative insult was able to indu …
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016.
Tomás CC, Oliveira E, Sousa D, Uba-Chupel M, Furtado G, Rocha C, Teixeira A, Ferreira P, Alves C, Gisin S, Catarino E, Carvalho N, Coucelo T, Bonfim L, Silva C, Franco D, González JA, Jardim HG, Silva R, Baixinho CL, Presado MªH, Marques MªF, Cardoso ME, Cunha M, Mendes J, Xavier A, Galhardo A, Couto M, Frade JG, Nunes C, Mesquita JR, Nascimento MS, Gonçalves G, Castro C, Mártires A, Monteiro MªJ, Rainho C, Caballero FP, Monago FM, Guerrero JT, Monago RM, Trigo AP, Gutierrez ML, Milanés GM, Reina MG, Villanueva AG, Piñero AS, Aliseda IR, Ramirez FB, Ribeiro A, Quelhas A, Manso C, Caballero FP, Guerrero JT, Monago FM, Santos RB, Jimenez NR, Nuñez CG, Gomez IR, Fernandez MªJL, Marquez LA, Moreno AL, Huertas MªJT, Ramirez FB, Seabra D, Salvador MªC, Braga L, Parreira P, Salgueiro-Oliveira A, Arreguy-Sena C, Oliveira BF, Henriques MªA, Santos J, Lebre S, Marques A, Festas C, Rodrigues S, Ribeiro A, Lumini J, Figueiredo AG, Hernandez-Martinez FJ, Campi L, Quintana-Montesdeoca MªP, Jimenez-Diaz JF, Rodriguez-De-Vera BC, Parente A, Mata MªA, Pereira AMª, Fernandes A, Brás M, Pinto MªR, Parreira P, Basto ML, Rei AC, Mónico LM, Sousa G, Morna C, Freitas O, Freitas G, Jardim A, Vasconcelos … See abstract for full author list ➔ Tomás CC, et al. BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200. doi: 10.1186/s12913-016-1423-5. BMC Health Serv Res. 2016. PMID: 27409075 Free PMC article.
Lopes, Eujcely C. Santiago O45 Community Health screenings and self-reported chronic diseases Silvia Monteiro, Angelo Jesus, Armanda Colaco, Antonio Carvalho, Rita P. ...Dora Ferreira, Antonio Brito, Renato Fernandes O101 Efficiency of the enteral administration of fibbers …
Lopes, Eujcely C. Santiago O45 Community Health screenings and self-reported chronic diseases Silvia Monteiro, Angelo Jesus, Armanda …
Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens.
McCutcheon SR, Swartz AM, Brown MC, Barrera A, McRoberts Amador C, Siklenka K, Humayun L, Ter Weele MA, Isaacs JM, Reddy TE, Allen AS, Nair SK, Antonia SJ, Gersbach CA. McCutcheon SR, et al. Nat Genet. 2023 Dec;55(12):2211-2223. doi: 10.1038/s41588-023-01554-0. Epub 2023 Nov 9. Nat Genet. 2023. PMID: 37945901 Free PMC article.
We found that BATF3 overexpression promoted specific features of memory T cells and attenuated gene programs associated with cytotoxicity, regulatory T cell function, and exhaustion. Upon chronic antigen stimulation, BATF3 overexpression countered phenotypic and epigenetic …
We found that BATF3 overexpression promoted specific features of memory T cells and attenuated gene programs associated with cytotoxicity, r …
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial.
Faivre-Finn C, Vicente D, Kurata T, Planchard D, Paz-Ares L, Vansteenkiste JF, Spigel DR, Garassino MC, Reck M, Senan S, Naidoo J, Rimner A, Wu YL, Gray JE, Özgüroğlu M, Lee KH, Cho BC, Kato T, de Wit M, Newton M, Wang L, Thiyagarajah P, Antonia SJ. Faivre-Finn C, et al. J Thorac Oncol. 2021 May;16(5):860-867. doi: 10.1016/j.jtho.2020.12.015. Epub 2021 Jan 19. J Thorac Oncol. 2021. PMID: 33476803 Free article. Clinical Trial.
Chronic hepatitis B: Advances in treatment.
Santantonio TA, Fasano M. Santantonio TA, et al. World J Hepatol. 2014 May 27;6(5):284-92. doi: 10.4254/wjh.v6.i5.284. World J Hepatol. 2014. PMID: 24868322 Free PMC article. Review.
Treatment of chronic hepatitis B (CHB) has markedly improved in the last 15 years due to the availability of direct antivirals which greatly increase therapeutic options. ...In this review, we focus on current treatment strategies of chronic hepatitis B and discuss …
Treatment of chronic hepatitis B (CHB) has markedly improved in the last 15 years due to the availability of direct antivirals which …
[Chronic pancreatitis : Characterization and differentiation from pancreatic cancer].
Kristic A, Bastati N, Poetter-Lang S, Messner A, Herold A, Tamandl D, Ba-Ssalamah A. Kristic A, et al. Radiologe. 2021 Jun;61(6):563-571. doi: 10.1007/s00117-021-00857-9. Epub 2021 May 17. Radiologe. 2021. PMID: 34002282 Free PMC article. Review. German.
CLINICAL/METHODOLOGICAL ISSUE: Chronic pancreatitis (CP) is a long-lasting inflammation of the pancreas that changes the normal structure and function of the organ. ...
CLINICAL/METHODOLOGICAL ISSUE: Chronic pancreatitis (CP) is a long-lasting inflammation of the pancreas that changes the normal struc …
Iron and multiple sclerosis.
Stankiewicz JM, Neema M, Ceccarelli A. Stankiewicz JM, et al. Neurobiol Aging. 2014 Sep;35 Suppl 2:S51-8. doi: 10.1016/j.neurobiolaging.2014.03.039. Epub 2014 May 15. Neurobiol Aging. 2014. PMID: 24929968 Free article. Review.
Several studies have suggested a link between brain iron deposition in normal aging and chronic neurologic diseases, including multiple sclerosis (MS). In MS, it is still not clear whether iron deposition is an epiphenomenon or a mediator of disease processes. ...
Several studies have suggested a link between brain iron deposition in normal aging and chronic neurologic diseases, including multip …
Evaluating treatment response of chronic myeloid leukemia: emerging science and technology.
Cagnetta A, Garuti A, Marani C, Cea M, Miglino M, Rocco I, Palermo C, Fugazza G, Cirmena G, Colombo N, Grasso R, Nencioni A, Gobbi M, Patrone F. Cagnetta A, et al. Curr Cancer Drug Targets. 2013 Sep;13(7):779-90. doi: 10.2174/15680096113139990084. Curr Cancer Drug Targets. 2013. PMID: 23906053 Review.
Chronic myeloid leukemia (CML) is a hematological disease accounting for about 15-20% of all adult leukemias. ...
Chronic myeloid leukemia (CML) is a hematological disease accounting for about 15-20% of all adult leukemias. ...
80 results